-
MITSUBISHI TANABE PHARMA CORPORATION et al v. MSN LABORATORIES PRIVATE LTD. et al DC
- 1:19-cv-15616
- D.N.J.
- Judge: Renee Marie Bumb
+1
- Filed: 07/19/2019
- Closed: 08/19/2021
- Latest Docket Entry: 08/19/2021
- PACER
- Docket updated daily
5
Plaintiffs
2
Defendants
1
Accused
Product
2
Patents-in-Suit
763
Days in
Litigation
-
MITSUBISHI TANABE PHARMA CORPORATION et al v. MSN LABORATORIES PRIVATE LTD. et al DC
- 1:19-cv-15616
- D.N.J.
- Judge: Renee Marie Bumb
+1
- Filed: 07/19/2019
- Closed: 08/19/2021
- Latest Docket Entry: 08/19/2021
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim | Outcome |
|---|---|
| All challenged claims |
Enforceable and Valid
Entry 19 |
-
Infringement
MSN Laboratories PVT Limited
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic versions of JPI’s canagliflozin and metformin hydrochloride extended-release 150 mg/1000 mg tablets | US 7,943,582 B2 | All Asserted Claims |
Infringement
Entry 19Entry 22 |
| Generic versions of JPI’s canagliflozin and metformin hydrochloride extended-release 150 mg/1000 mg tablets | US 8,513,202 B2 | All Asserted Claims |
Infringement
Entry 19
|
MSN Pharmaceuticals, Inc.
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic versions of JPI’s canagliflozin and metformin hydrochloride extended-release 150 mg/1000 mg tablets | US 7,943,582 B2 | All Asserted Claims |
Infringement
Entry 19Entry 22 |
| Generic versions of JPI’s canagliflozin and metformin hydrochloride extended-release 150 mg/1000 mg tablets | US 8,513,202 B2 | All Asserted Claims |
Infringement
Entry 19
|
